BioCentury
ARTICLE | Company News

AbCelex Technologies Inc., National Research Council of Canada deal

April 25, 2011 7:00 AM UTC

The National Research Council's Institute for Biological Sciences granted diagnostic company AbCelex exclusive, worldwide rights to develop and commercialize the Pentabody platform for all in vivo cli...